Updated data from India’s Covaxin’s final phase of trials shows that the vaccine can “neutralise” deadly mutations – including the double mutant. WION’s Palki Sharma tells you more. An interim analysis of the final phase data.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.